Mark A. Beaudet
Chief Executive Officer at Labopharm USA, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Samira Sakhia | F | 55 |
Labopharm USA, Inc.
| 11 years |
| Stephen Lemieux | M | 48 |
Cipher Pharmaceuticals US LLC
 Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | 4 years |
| Jonathan Goodman | M | 56 | 11 years | |
| Anna Martini | F | 61 |
McGill University Health Centre Foundation
| - |
| Christian Godin | M | - |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | 8 years |
| Stephen R. Wiseman | M | 77 |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | 13 years |
| James Gale | M | 74 | 10 years | |
| Stefan Aigner | M | 58 |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | 11 years |
| Craig Mull | M | - | 5 years | |
| Damon C. Smith | M | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Thomas Wellner | M | 59 |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | 4 years |
| Sylvain Guénette | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Guy Chamberland | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Pierre Gfeller | M | - |
McGill University Health Centre Foundation
| 6 years |
| Sacha Haque | M | - |
McGill University Health Centre Foundation
| 8 years |
| Sonia Gervais | F | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Aurelia de Pauw | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Nadine Renaud-Tinker | F | - |
McGill University Health Centre Foundation
| 2 years |
| Steeve Néron | M | - |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | - |
| Ivan Vella | M | - |
McGill University Health Centre Foundation
| 2 years |
| Jacques Filion | M | - |
McGill University Health Centre Foundation
| 2 years |
| Diane Gajewczyk | M | - | 6 years | |
| Tania Clarke | F | - |
McGill University Health Centre Foundation
| 2 years |
| Vincent Chiara | M | - |
McGill University Health Centre Foundation
| 2 years |
| A. Craighead | M | 64 |
McGill University Health Centre Foundation
| - |
| Ian Edwards | M | 61 |
McGill University Health Centre Foundation
| 2 years |
| Marie-Josée Lamothe | F | 56 |
McGill University Health Centre Foundation
| 2 years |
| Danny Gagné | M | - |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | - |
| Jean-Francois Leprince | M | - |
ILKOS THERAPEUTICS, Inc.
ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | - |
| Dale MacCandlish-Weil | F | 68 |
McGill University Health Centre Foundation
| - |
| Marc Parent | M | 63 |
McGill University Health Centre Foundation
| 6 years |
| Harold Wolkin | M | 72 |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | - |
| Marc Tellier | M | 55 |
McGill University Health Centre Foundation
| 2 years |
| John Mull | M | 90 |
Cipher Pharmaceuticals US LLC
Cipher Pharmaceuticals US LLC Medical/Nursing ServicesHealth Services Cipher Pharmaceuticals US LLC engages in providing laboratory testing and medical imaging services. It offers prescription dermatology, consumer skin care and additional products. The company is headquartered in Charleston, SC. | - |
| Mark Smith | M | - |
McGill University Health Centre Foundation
| 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Tessarolo | M | 56 | 2 years | |
| Gerald P. McDole | M | 84 | 12 years | |
| William D. Claypool | M | 72 | 7 years | |
| Sylvie Tendler | F | - | - | |
| Hillel W. Rosen | M | - | 1 years | |
| Gabrielle Lobban | F | - | - | |
| Laurence Terrisse-Rulleau | M | - | 1 years | |
| Jeffrey Kadanoff | M | 53 | 3 years | |
| Norman Evans | M | 70 | 9 years | |
| Shawn O'Brien | M | - | 3 years | |
| Andrew David Bonamour | M | 53 | 4 years | |
| Mark Nawacki | M | 54 | 2 years | |
| Michael Milloy | M | - | - | |
| Chris Watters | M | - | - | |
| Arthur M. Deboeck | M | - | - | |
| Brian Rosenberger | M | 55 | 2 years | |
| Tuan Elstrom | M | - | 2 years | |
| Linda Angaritis | F | - | 4 years | |
| Lynne Bulger | F | - | 2 years | |
| Joan Chypyha | F | 57 | 4 years | |
| Hermanth Varghese | M | 49 | - | |
| Peter Weiler | M | - | 9 years | |
| Suketu Upadhyay | M | 55 | - | |
| Ralph Bohrer | M | - | 1 years | |
| Rosemary Crane | F | 64 | - | |
| Renee Tannenbaum | M | 72 | - | |
| William Marshall-Smith | M | 46 | 4 years | |
| Nadine Jutlah | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 55 | 87.30% |
| United States | 8 | 12.70% |
| South Africa | 6 | 9.52% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark A. Beaudet
- Personal Network
